The average P/S ratio for ASTH's competitors is 1.14, providing a benchmark for relative valuation. Astrana Health Inc Corp (ASTH) exhibits a P/S ratio of 0.36, which is -68.72% above the industry average. Given its robust revenue growth of 53.43%, this premium appears sustainable.